Henning Beck-Nielsen

Search results

• Hvad er de reelle årsager til type 2 diabetes

  Beck-Nielsen, H. (Lecturer)

  21. Nov 2016

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Efficacy of novel antidiabetic agents

  Beck-Nielsen, H. (Lecturer)

  17. Nov 2016 → 20. Nov 2016

  Activity: Talks and presentations › Talks and presentations in private or public companies

• How important is lactic acidosis as complication of metformin therapy?

  Beck-Nielsen, H. (Lecturer)

  12. Sept 2016 → 16. Sept 2016

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Diabetes mellitus: Individualised approach

  Beck-Nielsen, H. (Lecturer)

  17. Jun 2016

  Activity: Talks and presentations › Talks and presentations in private or public companies

• SGLT2 Inhibitors and Diabetic Ketoacidosis - “The European Experience"

  Beck-Nielsen, H. (Lecturer)

  24. Oct 2015 → 25. Oct 2015

  Activity: Talks and presentations › Talks and presentations in private or public companies

• The Type 2 Diabetes Epidemic – Pathophysiology, treatment and prevention

  Beck-Nielsen, H. (Lecturer)

  21. Oct 2015

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Diabetes mellitus: Individualised approach

  Beck-Nielsen, H. (Lecturer)

  17. Jun 2015

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Type 2 diabetes er flere sykdommer - konsekvenser for behandling

  Beck-Nielsen, H. (Lecturer)

  23. Apr 2015

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Future treatment of type 2 diabetes based on pathophysiological phenotypes

  Beck-Nielsen, H. (Lecturer)

  7. Nov 2014

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Individualized Treatment in Type 2 Diabetes is Cost-effective

  Beck-Nielsen, H. (Lecturer)

  22. Oct 2014

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Dagens Medicin: Vejen til bedre diabetesbehandling

  Beck-Nielsen, H. (Speaker)

  3. Oct 2014 → …

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Metabolic abnormities associated with LADA

  Beck-Nielsen, H. (Lecturer)

  4. Jun 2014

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Future treatment of type 2 diabetes based on pathophysiological phenotypes

  Beck-Nielsen, H. (Lecturer)

  17. Jan 2014

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Pathophysiologic phenotypes of patients clinically diagnosed as type 2 diabetes

  Beck-Nielsen, H. (Lecturer)

  23. Sept 2013 → 27. Sept 2013

  Activity: Talks and presentations › Talks and presentations in private or public companies

• DD2 - A nationwide study for prevention of complications in type 2 diabetes

  Beck-Nielsen, H. (Lecturer)

  30. May 2013

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Tailored treatment of type 2 diabetes based on present pathophysiology

  Beck-Nielsen, H. (Lecturer)

  10. May 2013

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Diabetes mellitus: En folkesygdom i hastig udvikling

  Beck-Nielsen, H. (Lecturer)

  2. May 2013

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Type 2 diabetes: Ætiologi og patogenese

  Beck-Nielsen, H. (Lecturer)

  26. Feb 2013

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Metabolic abnormalities in skeletal muscle in type 2 diabetes

  Beck-Nielsen, H. (Lecturer)

  28. Jan 2013

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Molecular defects in glucose disposal in skeletal muscles from subjects with type 2 diabetes

  Beck-Nielsen, H. (Lecturer)

  7. Jun 2012

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Behandling af type 1 diabetes - hvad bringer fremtiden?

  Beck-Nielsen, H. (Lecturer)

  3. May 2012

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Diabetes and influence on vessels and nerves

  Beck-Nielsen, H. (Lecturer)

  26. Apr 2012

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Diabetes mellitus

  Beck-Nielsen, H. (Lecturer)

  20. Apr 2012

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Type 2 diabetes

  Beck-Nielsen, H. (Lecturer)

  15. Mar 2012

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Det metaboliske syndrom i daglig klinik

  Beck-Nielsen, H. (Lecturer)

  3. Nov 2011

  Activity: Talks and presentations › Talks and presentations in private or public companies

• The 10th Congress of the European Association for Clinical Pharmacology and Therapeutics

  Beck-Nielsen, H. (Speaker)

  26. Jun 2011 → 29. Jun 2011

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Should presence of cardiovascular disease determine glycaemia target?

  Beck-Nielsen, H. (Lecturer)

  25. May 2011

  Activity: Talks and presentations › Talks and presentations in private or public companies

• A hypoglycaemia alarm based on continuous EEG monitoring and real-time data processing

  Beck-Nielsen, H. (Lecturer)

  2011

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Endocrine Research Unit

  Beck-Nielsen, H. (Lecturer)

  26. Nov 2010

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Organisation of Diabetes Carein Denmark

  Beck-Nielsen, H. (Lecturer)

  11. Nov 2010

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Hypoglykæmi

  Beck-Nielsen, H. (Lecturer)

  30. Sept 2010

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Translational Science in the Metabolic Syndrome – future directions

  Beck-Nielsen, H. (Lecturer)

  20. Jul 2010

  Activity: Talks and presentations › Talks and presentations in private or public companies

• HOPE

  Beck-Nielsen, H. (Speaker)

  30. Jun 2010

  Activity: Talks and presentations › Talks and presentations in private or public companies

• The Pathophysiology of Type 2 Diabetesand LADA

  Beck-Nielsen, H. (Lecturer)

  9. Jun 2010

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Fokus på nye og kommende proteinbaserede diabetes-lægemidler

  Beck-Nielsen, H. (Lecturer)

  4. May 2010

  Activity: Talks and presentations › Talks and presentations in private or public companies

•   T2D - Fra epidemiologi til individuel behandling

  Beck-Nielsen, H. (Lecturer)

  4. May 2010

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Insulin treatment – from August Krogh to the artificial pancreas

  Beck-Nielsen, H. (Lecturer)

  2010

  Activity: Talks and presentations › Talks and presentations in private or public companies

• EVALUATION OF CLINICAL RESEARCH IN FINLAND AND SWEDEN

  Beck-Nielsen, H. (Lecturer)

  20. Nov 2009

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Rosiglitazone Evaluated for Cardiovascular Outcome and Regulation of Glycaemia in Diabetes

  Beck-Nielsen, H. (Lecturer)

  3. Nov 2009

  Activity: Talks and presentations › Talks and presentations in private or public companies

•   Rosiglitazone Evaluated for Cardiovascular Outcome and Regulation of Glycaemia in Diabetes

  Beck-Nielsen, H. (Lecturer)

  20. Oct 2009

  Activity: Talks and presentations › Talks and presentations in private or public companies

•   The Pathophysiology of Type 2 Diabetes

  Beck-Nielsen, H. (Lecturer)

  5. Oct 2009

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Effect of hyperglycaemia on whole-body glucose metabolism and muscle glycogen synthase activity during physiological hyperinsulinaemia in type 2 diabetes

  Beck-Nielsen, H. (Speaker)

  30. Sept 2009 → 2. Oct 2009

  Activity: Talks and presentations › Talks and presentations in private or public companies

•   Nye landvindinger i diabetesbehandlingen

  Beck-Nielsen, H. (Lecturer)

  24. Sept 2009

  Activity: Talks and presentations › Talks and presentations in private or public companies

•   Organisation of Diabetes Carein Denmark

  Beck-Nielsen, H. (Lecturer)

  24. Sept 2009

  Activity: Talks and presentations › Talks and presentations in private or public companies

•   Clinical aspects of type 2 diabetes

  Beck-Nielsen, H. (Lecturer)

  26. Aug 2009

  Activity: Talks and presentations › Talks and presentations in private or public companies

• Rosiglitazone Evaluated for Cardiovascular Outcome and Regulation of Glycaemia in Diabetes

  Beck-Nielsen, H. (Lecturer)

  6. Jul 2009

  Activity: Talks and presentations › Talks and presentations in private or public companies

•   Rosiglitazone Evaluated for Cardiovascular Outcome and Regulation of Glycaemia in Diabetes

  Beck-Nielsen, H. (Lecturer)

  30. Jun 2009

  Activity: Talks and presentations › Talks and presentations in private or public companies

•   The Dysmetabolic Syndrome

  Beck-Nielsen, H. (Lecturer)

  25. May 2009

  Activity: Talks and presentations › Talks and presentations in private or public companies

•   Nye landvindinger i diabetesbehandlingen

  Beck-Nielsen, H. (Lecturer)

  5. May 2009

  Activity: Talks and presentations › Talks and presentations in private or public companies

•   Diabetesomsorg - Fra Fyn og tilbage igen

  Beck-Nielsen, H. (Lecturer)

  6. Mar 2009

  Activity: Talks and presentations › Talks and presentations in private or public companies